Bibliography: Emerging Therapies in Psychiatry
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
2018
Canuso CMSJ, Singh JB, Fedgchin M, et al: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry (Epub ahead of print, April 16, 2018)
Freedman R, Brown AS, Cannon TD, et al: Can a framework be established for the safe use of ketamine? Am J Psychiatry (Epub ahead of print, April 16, 2018)
Grunebaum MF, Galfalvy HC, Choo TH, et al: Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335
Khalsa SS, Adolphs R, Cameron OG, et al: Interoception and mental health: a roadmap. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging doi: 10.1016/j.bpsc.2017.12.004
McClintock SM, Reti IM, Carpenter LL, et al: Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (RTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:16cs10905
Widge AS, Malone DA Jr, Dougherty DD: Closing the loop on deep brain stimulation for treatment-resistant depression. Front Neurosci 2018; 12:175
Wilkinson ST, Ballard ED, Bloch MH, et al: The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 2018; 175:150–158
Zanos P, Thompson SM, Duman RS, et al: Convergent mechanisms underlying rapid antidepressant action. CNS Drugs 2018; 32:197–227
2017
Alyami M, Giri B, Alyami H, et al: Social anxiety apps: a systematic review and assessment of app descriptors across mobile store platforms. Evid Based Ment Health 2017; 20:65–70
Chan S, Godwin H, Gonzalez A, et al: Review of use and integration of mobile apps into psychiatric treatments. Curr Psychiatry Rep 2017; 19:96
Firth J, Torous J, Nicholas J, et al: Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord 2017; 218:15–22
Firth J, Torous J, Nicholas J, et al: The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry 2017; 16:287–298
Fortney JC, Unützer J, Wrenn G, et al: A tipping point for measurement-based care. Psychiatr Serv 2017; 68:179–188
Garay RP, Zarate CA Jr, Charpeaud T, et al: Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother 2017; 17:593–609
Hilty DM, Chan S, Hwang T, et al: Advances in mobile mental health: opportunities and implications for the spectrum of e-mental health services. mHealth 2017; 3:34
Hung SY, Fu WM: Drug candidates in clinical trials for Alzheimer’s disease. J Biomed Sci 2017; 24:47 [Review]
Insel TR: Digital phenotyping: technology for a new science of behavior. JAMA 2017; 318:1215–1216
Krystal JH, Abdallah CG, Averill LA, et al: Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep 2017; 19:74
Luik AI, Kyle SD, Espie CA: Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review. Curr Sleep Med Rep 2017; 3:48–56
Maples-Keller JL, Bunnell BE, Kim SJ, et al: The use of reality technology in the treatment of anxiety and other psychiatric disorders. Harvard Review of Psychiatry 2015; 25(3):103–113
Naumann J, Grebe J, Kaifel S, et al: Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial. BMC Complement Altern Med 2017; 17:172
Rizzo AS, Koenig ST: Is clinical virtual reality ready for primetime? Neuropsychology 2017; 31:877–899
Wilkinson ST, Wright D, Fasula MK, et al: Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression. Psychother Psychosom 2017; 86:162–167
2016
Armontrout J, Torous J, Fisher M, et al: Mobile mental health: navigating new rules and regulations for digital tools. Curr Psychiatry Rep 2016; 18:91, 016–0726, x
Duman RS, Aghajanian GK, Sanacora G, et al: Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 2016; 22:238–249
Fawcett J, Rush AJ, Vukelich J, et al: Clinical experience with high-dosage pramipexole in patients with treatment-resistant depressive episodes in unipolar and bipolar depression. Am J Psychiatry 2016; 173:107–111
Garay RP, Citrome L, Grossberg GT, et al: Investigational drugs for treating agitation in persons with dementia. Expert Opin Investig Drugs 2016; 25:973–983
Inagaki TK, Irwin MR, Moieni M, et al: A Pilot study examining physical and social warmth: higher (non-febrile) oral temperature is associated with greater feelings of social connection. PLoS One 2016; 11:e0156873
Possemato K, Kuhn E, Johnson E, et al: Using PTSD Coach in primary care with and without clinician support: a pilot randomized controlled trial. Gen Hosp Psychiatry 2016; 38:94–98
Ranallo PA, Kilbourne AM, Whatley AS, et al: Behavioral health information technology: from chaos to clarity. Health Aff (Millwood) 2016; 35:1106–1113
Redlich R, Opel N, Grotegerd D, et al: Prediction of individual response to electroconvulsive therapy via machine learning on structural magnetic resonance imaging data. JAMA Psychiatry 2016; 73:557–564
Sarris J, Murphy J, Mischoulon D, et al: Adjunctive nutraceuticals for depression: a systematic review and meta-analyses. Am J Psychiatry 2016; 173:575–587
Singh JB, Fedgchin M, Daly E, et al: Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study. Biol Psychiatry 2016; 80:424–431
Further Reading
Berlim MT, van den Eynde F, Tovar-Perdomo S, et al: Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014; 44:225–239
Firth J, Torous J: Smartphone apps for schizophrenia: a systematic review. JMIR Mhealth Uhealth 2015; 3:e102
Jain SH, Powers BW, Hawkins JB, et al: The digital phenotype. Nat Biotechnol 2015; 33:462–463
Nicholas J, Larsen ME, Proudfoot J, et al: Mobile apps for bipolar disorder: a systematic review of features and content quality. J Med Internet Res 2015; 17:e198
Raison CL, Hale MW, Williams LE, et al: Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems. Front Psychol 2015; 5:1580
Information & Authors
Information
Published In
History
Published in print: Summer 2018
Published online: 18 July 2018
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).